Institutional Ownership Xilio Therapeutics, Inc. (XLO)
This table provides information about the institutional ownership of Xilio Therapeutics, Inc. (XLO). We have compiled data on the 35 institutions that hold shares in the stock, with a total of 12.8 Million shares, which have been reported (via 13F filing form) to have a value of $8.95 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Bain Capital Life Sciences Investors, LLC
Boston, MA |
Aug 14, 2025 Q2 2025 |
4,566,817
shares
|
$3.2 Million
0.93% of portfolio
|
Q3 2024
Added 20.64%
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
1,444,326
shares
|
$1.01 Million
0.0% of portfolio
|
Q2 2025
Added 24.96%
|
|
River Vest Venture Management LLC
St. Louis, MO |
Oct 30, 2024 Q3 2024 |
1,441,444
shares
|
$1.01 Million
16.6% of portfolio
|
Q4 2021
New holding
|
|
Ghisallo Capital Management LLC
Greenwich, CT |
Aug 13, 2025 Q2 2025 |
1,333,000
shares
|
$933,099
0.05% of portfolio
|
Q2 2025
New holding
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
1,151,023
shares
|
$805,716
0.0% of portfolio
|
Q2 2025
Added 1.35%
|
|
Aju Ib Investment Co., Ltd.
Seoul, M5 |
Jul 10, 2025 Q2 2025 |
667,742
shares
|
$467,419
0.5% of portfolio
|
Q4 2021
New holding
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
369,660
shares
|
$258,761
0.0% of portfolio
|
Q2 2025
Reduced 2.47%
|
|
Trustees Of Columbia University In The City Of New York
New York, NY |
Aug 14, 2025 Q2 2025 |
249,635
shares
|
$174,744
0.02% of portfolio
|
Q4 2022
New holding
|
|
Ubs Group Ag
|
Aug 14, 2025 Q2 2025 |
239,969
shares
|
$167,978
0.0% of portfolio
|
Q2 2025
Added 47.13%
|
|
Squarepoint Ops LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
235,456
shares
|
$164,819
0.0% of portfolio
|
Q2 2025
New holding
|
|
Balyasny Asset Management LLC
Chicago, IL |
Aug 14, 2025 Q2 2025 |
198,859
shares
|
$139,201
0.0% of portfolio
|
Q2 2025
Reduced 21.82%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 13, 2025 Q2 2025 |
164,200
shares
|
$114,939
0.0% of portfolio
|
Q2 2025
Reduced 7.6%
|
|
Avantax Planning Partners, Inc.
|
Aug 11, 2025 Q2 2025 |
142,338
shares
|
$99,636
0.0% of portfolio
|
Q2 2025
Reduced 5.36%
|
|
Two Sigma Investments, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
78,032
shares
|
$54,622
0.0% of portfolio
|
Q2 2025
Reduced 7.18%
|
|
Northern Trust Corp
Chicago, IL |
Aug 13, 2025 Q2 2025 |
66,609
shares
|
$46,626
0.0% of portfolio
|
Q1 2025
Added 69.89%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
66,418
shares
|
$46,492
0.0% of portfolio
|
Q2 2024
Added 46.44%
|
|
Bridgeway Capital Management, LLC
Houston, TX |
Aug 14, 2025 Q2 2025 |
56,081
shares
|
$39,256
0.0% of portfolio
|
Q2 2025
Reduced 21.1%
|
|
Seven Bridge Financial Group, LLC
|
May 13, 2025 Q1 2025 |
46,000
shares
|
$32,199
0.01% of portfolio
|
Q1 2025
Added 12.2%
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
43,390
shares
|
$30,372
0.0% of portfolio
|
Q2 2024
Added 176.55%
|
|
Raymond James & Associates
St Petersburg, FL |
Oct 18, 2024 Q3 2024 |
38,825
shares
|
$27,177
0.0% of portfolio
|
Q2 2024
New holding
|
|
Xtx Topco LTD
London, X0 |
Aug 12, 2025 Q2 2025 |
34,721
shares
|
$24,304
0.0% of portfolio
|
Q2 2025
New holding
|
|
Lpl Financial LLC
Fort Mill, SC |
Aug 12, 2025 Q2 2025 |
31,000
shares
|
$21,700
0.0% of portfolio
|
Q2 2025
New holding
|
|
Aptus Capital Advisors, LLC
|
Aug 11, 2025 Q2 2025 |
25,000
shares
|
$17,500
0.0% of portfolio
|
Q2 2025
Reduced 45.65%
|
|
Mariner, LLC
Overland Park, KS |
Aug 14, 2025 Q2 2025 |
25,000
shares
|
$17,500
0.0% of portfolio
|
Q4 2024
Reduced 1.25%
|
|
Raymond James Financial Inc
St. Petersburg, FL |
Aug 14, 2025 Q2 2025 |
18,761
shares
|
$13,132
0.0% of portfolio
|
Q2 2025
Reduced 44.76%
|